FSA Analysis
FSA Analysis | 9 May 19
Greater China equity funds boosted by TMT exposure
The best performing Greater China equity funds over the long-term have made substantial allocations to the TMT sector.
Sharpe fund houses in the spotlight
Two asset management firms run the most funds with the highest risk-adjusted returns over three years.
Asset Class in Focus | 25 Mar 19
TMT fund sector is the standout performer
The tech sector has posted the best absolute and risk-adjusted returns during the past three years, despite its headline-grabbing volatility.
Asset Class in Focus | 17 Dec 18
Only four fund sectors positive in 2018
This year’s best performing fund category in the Hong Kong universe was actually 2017’s worst performer.
China equity funds collapse in October
Investors had no place to go but down in October. Which China funds fared the best and worst?
Asset Class in Focus | 23 Oct 18
Asia’s fund selectors like slumping Chinese equities
In the next 12 months, research suggests that allocations to China equity funds will be up while US and European equity product exposure will decrease, according to data collected by FSA.
Asset Class in Focus | 6 Jun 18
Can pharma and biotech ease pain in a financial crisis?
Ten years after the global financial crisis of 2008, FSA notes that pharmaceutical, healthcare and biotech stocks weathered that year better than other sectors.
Asset Class in Focus | 31 May 18
Are policy funds staying true-to-label?
Riding China’s policy bus is not as easy as it sounds, as the poor performance of China policy-driven funds shows.
Asset Class in Focus | 22 Sep 17
The myth of ESG outperformance
Part two of a look at the hype surrounding the ESG theme finds that there are sound reasons to be skeptical about claims that ESG investments outperform the general market.
